Choisir une catégorie :

- Valbiotis announces the positive results of its clinical study on the bioavailability and mode of action of TOTUM•070,against hypercholesterolemia.

Voir le communiqué de presse

- Valbiotis is strengthening its commitment to CSR by joining the United Nations Global Compact and applying the ISO 26000 standard

Voir le communiqué de presse

- Valbiotis announces approval to launch the two Phase II/III INSIGHT and INSIGHT 2 clinical studies, the last step in the development of TOTUM•854 for the reduction of blood pressure.

Voir le communiqué de presse

- Icare Group, an expert in the control of health product safety, has created the customizable mask holder (IN FRENCH).

Voir le communiqué de presse